Biological activity of ruthenium nitrosyl complexes

Nitric Oxide - Biology and Chemistry

Volumn 26, Issue 1, 2012, Pages 38-53

  Tfouni, Elia ^a   Truzzi, Daniela Ramos ^a   Tavares, Aline ^a   Gomes, Anderson Jesus ^b   Figueiredo, Leonardo Elias ^a   Franco, Douglas Wagner ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Nitric oxide carriers; Reactivity and biologic activity; Ruthenium nitrosyls

Indexed keywords

ANTIINFECTIVE AGENT; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RUTHENIUM COMPLEX; RUTHENIUM NITROSYL COMPLEX; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CHEMICAL REACTION; CHEMICAL STRUCTURE; ELECTRON TRANSPORT; ENDOTHELIUM CELL; INFECTION PREVENTION; LIGHT EXPOSURE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; OXIDATION; PHOTOCHEMISTRY; PHOTOLYSIS; PRIORITY JOURNAL; REDUCTION; REVIEW; VASOCONSTRICTION; VASODILATATION;

AMINES; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPROTOZOAL AGENTS; BLOOD PRESSURE; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LEISHMANIASIS, CUTANEOUS; MICE; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMISTRY; RUTHENIUM; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

LEISHMANIA MAJOR; MUS; TRYPANOSOMA CRUZI;

EID: 84155173535     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2011.11.005     Document Type: Review

References (240)

1. G. Stochel, A. Wanat, E. Kulis, and Z. Stasicka Light and metal complexes in medicine Coordination Chemistry Reviews 171 1998 203 220
2. L. Ronconi, and P.J. Sadler Using coordination chemistry to design new medicines Coordination Chemistry Reviews 251 2007 1633 1648
3. S.P. Fricker Metal based drugs: from serendipity to design Dalton Transactions 2007 4903 4917 (Pubitemid 350015415)
4. M.J. Clarke, F. Zhu, and D.R. Frasca Non-platinum chemotherapeutic metallopharmaceuticals Chemical Reviews 99 1999 2511 2534
5. P.J. Dyson, and G. Sava Metal-based antitumour drugs in the post genomic era Dalton Transactions 2006 1929 1933 (Pubitemid 43797525)
6. A. Levina, A. Mitra, and P.A. Lay Recent developments in ruthenium anticancer drugs Metallomics 1 2009 458 470
7. J.N. Bates, M.T. Baker, R. Guerra Jr. , and D.G. Harrison Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required Biochemical Pharmacology 42 Supplement 1 1991 S157 S165
8. J. Forestier Rheumatoid arthritis and its treatment by gold salts - The results of six years experience Journal of Laboratory and Clinical Medicine 20 1935 827 840
9. M. Navarro Gold complexes as potential anti-parasitic agents Coordination Chemistry Reviews 253 2009 1619 1626
10. Available at < http://www.who.int/nutrition/publications/ micronutrients/anaemia-iron-deficiency/en/ >, World Health Organization, accessed 10 August 2011.
11. E. Hillard, A. Vessieres, L. Thouin, G. Jaouen, and C. Amatore Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates Angewandte Chemie-International Edition 45 2006 285 290 (Pubitemid 43017528)
12. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric-Oxide - physiology Pathophysiology, and Pharmacology. Pharmacological Reviews 43 1991 109 142
13. C. Glidewell, and I.L. Johnson Definitive identification of the primary reduction product of the nitroprusside ion, pentacyanonitrosylferrate(2-), in aqueous-solution Inorganica Chimica Acta 132 1987 145 147
14. Available at < http://whqlibdoc.who.int/hq/2011/a95053-eng.pdf >, World Health Organization, accessed 10 August 2011.
15. P.A. Lay, and W.D. Harman Recent advances in osmium chemistry Advances in Inorganic Chemistry 37 1991 219 379
16. A.F.A. Peacock, A. Habtemariam, R. Fernandez, V. Walland, F.P.A. Fabbiani, S. Parsons, R.E. Aird, D.I. Jodrell, and P.J. Sadler Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions Journal of the American Chemical Society 128 2006 1739 1748 (Pubitemid 43214890)
17. D.T. Richens The chemistry of aqua ions: synthesis, structure, and reactivity: a tour through the periodic table of the elements 1997 Wiley New York
18. A.F.A. Peacock, S. Parsons, and P.J. Sadler Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity Journal of the American Chemical Society 129 2007 3348 3357 (Pubitemid 46449365)
19. M.J. Clarke Ruthenium metallopharmaceuticals Coordination Chemistry Reviews 232 2002 69 93
20. U. Schatzschneider Photoactivated biological activity of transition-metal complexes European Journal of Inorganic Chemistry 2010 2010 1451 1467
21. E. Tfouni Photochemical reactions of ammineruthenium(II) complexes Coordination Chemistry Reviews 196 2000 281 305
22. E. Tfouni, F.G. Doro, L.E. Figueiredo, J.C.M. Pereira, G. Metzker, and D.W. Franco Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic tetraazamacrocycles Current Medicinal Chemistry 17 2010 3643 3657
23. E. Tfouni, F.G. Doro, A.J. Gomes, R.S.d. Silva, G. Metzker, P.G.Z. Benini, and D.W. Franco Immobilized ruthenium complexes and aspects of their reactivity Coordination Chemistry Reviews 254 2010 355 371
24. E. Tfouni, K.Q. Ferreira, F.G. Doro, R.S. da Silva, and Z.N. da Rocha Ru(II) and Ru(III) complexes with cyclam and related species Coordination Chemistry Reviews 249 2005 405 418 (Pubitemid 40093749)
25. E. Tfouni, M. Krieger, B.R. McGarvey, and D.W. Franco Structure, chemical and photochemical reactivity and biological activity of some ruthenium amine nitrosyl complexes Coordination Chemistry Reviews 236 2003 57 69
26. J.F. Vollano, G.E. Bossard, S.A. Martellucci, M.C. Darkes, M.J. Abrams, and R.C. Brooks The synthesis and in vitro photodynamic activity of a series of novel ruthenium(II)-2, 3-naphthalocyanines Journal of Photochemistry and Photobiology B: Biology 37 1997 230 235 (Pubitemid 27117022)
27. A.A. Eroy-Reveles, and P.K. Mascharak Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery Future Medicinal Chemistry 1 2009 1497 1507
28. N.J. Farrer, L. Salassa, and P.J. Sadler Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine Dalton Transactions 2009 10690 10701
29. P.C. Ford Polychromophoric metal complexes for generating the bioregulatory agent nitric oxide by single- and two-photon excitation Accounts of Chemical Research 41 2008 190 200
30. P.C. Ford, and I.M. Lorkovic Mechanistic aspects of the reactions of nitric oxide with transition-metal complexes Chemical Reviews 102 2002 993 1018
31. x generation Coordination Chemistry Reviews 249 2005 1382 1395 (Pubitemid 41078789)
32. 2O encapsulated in PLGA microparticles for delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity Journal of Inorganic Biochemistry 102 2008 757 766
33. A.D. Ostrowski, and P.C. Ford Metal complexes as photochemical nitric oxide precursors: potential applications in the treatment of tumors Dalton Transactions 2009 10660 10669
34. M.J. Rose, and P.K. Mascharak Photoactive ruthenium nitrosyls: effects of light and potential application as NO donors Coordination Chemistry Reviews 252 2008 2093 2114
35. P.S. Wagenknecht, and P.C. Ford Metal centered ligand field excited states: their roles in the design and performance of transition metal based photochemical molecular devices Coordination Chemistry Reviews 255 2011 591 616
36. D.S. Maranho, R.G. de Lima, F.L. Primo, R.S. da Silva, and A.C. Tedesco Photoinduced nitric oxide and singlet oxygen release from ZnPC liposome vehicle associated with the nitrosyl ruthenium complex: synergistic effects in photodynamic therapy application Photochemistry and Photobiology 85 2009 705 713
37. C.S. Allardyce, and P.J. Dyson Ruthenium in medicine: current clinical uses and future prospects Platinum Metals Review 45 2001 62
38. W.H. Ang, and P.J. Dyson Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy European Journal of Inorganic Chemistry 2006 4003 4018
39. J. Reedijk Metal-ligand exchange kinetics in platinum and ruthenium complexes Platinum Metals Review 52 2008
40. D.V. Deubel, and J.K.C. Lau In silico evolution of substrate selectivity: comparison of organometallic ruthenium complexes with the anticancer drug cisplatin Chemical Communications 2006 2451 2453 (Pubitemid 43877074)
41. G. Sava, I. Capozzi, K. Clerici, G. Gagliardi, E. Alessio, and G. Mestroni Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex Clinical & Experimental Metastasis 16 1998 371 379 (Pubitemid 28255532)
42. L. Rover, N.F. Hoehr, A.P. Vellasco, and L.T. Kubota Antioxidant system involving the glutathione metabolic cycle associated to electroanalytical methods in the oxidative stress evaluation Química Nova 24 2001 112 119 (Pubitemid 33678276)
43. F.P. Dwyer, E.C. Gyarfas, W.P. Rogers, and J.H. Koch Biological activity of complex ions Nature 170 1952 190 191
44. F.P. Dwyer, E. Mayhew, E.M. Roe, and A. Shulman Inhibition of landschuetz ascites tumour growth by metal chelates derived from 3, 4, 7, 8-tetramethyl-1, 10-phenanthroline British Journal of Cancer 19 1965 195 199
45. E. Meggers Exploring biologically relevant chemical space with metal complexes Current Opinion in Chemical Biology 11 2007 287 292 (Pubitemid 46963074)
46. A. Bergamo, and G. Sava Ruthenium complexes can target determinants of tumour malignancy Dalton Transactions 2007 1267 1272 (Pubitemid 46449547)
47. M.J. Clarke Oncological implications of the chemistry of ruthenium 1980 New York Marcel Dekker
48. M.J. Clarke Ruthenium chemistry pertaining to the design of anticancer agents, in ruthenium and other non-platinum metal complexes in cancer chemotherapy Progress in Clinical Biochemistry and Medicine 10 1989 25 39
49. M. Galanski, V.B. Arion, M.A. Jakupec, and B.K. Keppler Recent developments in the field of tumor-inhibiting metal complexes Current Pharmaceutical Design 9 2003 2078 2089 (Pubitemid 37142439)
50. C.G. Hartinger, S. Zorbas-Seifried, M.A. Jakupec, B. Kynast, H. Zorbas, and B.K. Keppler From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H- indazole)ruthenate(III)] (KP1019 or FFC14A) Journal of Inorganic Biochemistry 100 2006 891 904 (Pubitemid 44308176)
51. G. Sava, A. Bergamo, S. Zorzet, B. Gava, C. Casarsa, M. Cocchietto, A. Furlani, V. Scarcia, B. Serli, E. Iengo, E. Alessio, and G. Mestroni Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A European Journal of Cancer 38 2002 427 435 (Pubitemid 34123316)
52. S. Kapitza, M. Pongratz, M.A. Jakupec, P. Heffeter, W. Berger, L. Lackinger, B.K. Keppler, and B. Marian Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells Journal of Cancer Research and Clinical Oncology 131 2005 101 110 (Pubitemid 40192935)
53. C.G. Hartinger, M.A. Jakupec, S. Zorbas-Seifried, M. Groessl, A. Egger, W. Berger, H. Zorbas, P.J. Dyson, and B.K. Keppler KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients Chemistry & Biodiversity 5 2008 2140 2155
54. 3: hypotensive effect of endothelium-dependent and -independent vasodilators in different hypertensive animals models Nitric Oxide-Biology and Chemistry 7 2002 50 56 (Pubitemid 35007260)
55. J.J. Silva, A.L. Osakabe, W.R. Pavanelli, J.S. Silva, and D.W. Franco In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors British Journal of Pharmacology 152 2007 112 121 (Pubitemid 47339905)
56. J.C.M. Pereira, V. Carregaro, D.L. Costa, J.S. da Silva, F.Q. Cunha, and D.W. Franco Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes European Journal of Medicinal Chemistry 45 2010 4180 4187
57. R.Z. Osti, F.A. Serrano, T. Paschoalin, M. Massaoka, L.R. Travassos, D.R. Truzzi, E.G. Rodrigues, and D.W. Franco, The in vitro and in vivo antitumor activities of nitrosyl ruthenium am(m)ine complexes against murine and human tumor cell lines. British Journal of Pharmacology submitted for publication.
58. D.W. Franco Ruthenium ammine complexes of group Vb donor ligands Coordination Chemistry Reviews 119 1992 199 225
59. J. Bordini, D.O. Novaes, I.E. Borissevitch, B.T. Owens, P.C. Ford, and E. Tfouni Acidity and photolability of ruthenium salen nitrosyl and aquo complexes in aqueous solutions Inorganica Chimica Acta 361 2008 2252 2258
60. 3+ complexes Inorganica Chimica Acta 357 2004 1381 1388
61. J.C. Toledo, B.D.S.L. Neto, and D.W. Franco Mutual effects in the chemical properties of the ruthenium metal center and ancillary ligands upon coordination Coordination Chemistry Reviews 249 2005 419 431 (Pubitemid 40093750)
62. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from L-arginine Nature 333 1988 664 666
63. P. Pagliaro Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO Life Sciences 73 2003 2137 2149 (Pubitemid 36966171)
64. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiological Reviews 87 2007 315 424 (Pubitemid 46217686)
65. L.J. Ignarro Endothelium-derived nitric-oxide - actions and properties Faseb Journal 3 1989 31 36
66. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
67. J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends in Neurosciences 14 1991 60 67
68. J. Garthwaite Neural nitric oxide signalling Trends in Neurosciences 18 1995 51 52
69. J.B. Hibbs Jr. , R.R. Taintor, Z. Vavrin, and E.M. Rachlin Nitric oxide: a cytotoxic activated macrophage effector molecule Biochemical and Biophysical Research Communications 157 1988 87 94 (Pubitemid 19004828)
70. M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf, and J.S. Wishnok Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate Biochemistry 27 1988 8706 8711 (Pubitemid 19008186)
71. L.J. Ignarro Nitric Oxide Biology and Pathobiology 2000 Academic Press
72. J.A. McCleverty Chemistry of nitric oxide relevant to biology Chemical Reviews 104 2004 403 418
73. D.A. Wink, and J.B. Mitchell Nitric oxide and cancer: an introduction Free Radical Biology & Medicine 34 2003 951 954 (Pubitemid 36398555)
74. D.A. Wink, and J.B. Mitchell Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radical Biology & Medicine 25 1998 434 456 (Pubitemid 28390299)
75. L.K. Keefer Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities Current Topics in Medicinal Chemistry 5 2005 625 636 (Pubitemid 41179724)
76. L.K. Keefer, R.W. Nims, K.M. Davies, and D.A. Wink NONOates, (1-substituted diazen-1-ium-1, 2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms Methods in Enzymology 268 1996 281 293 (Pubitemid 26286370)
77. 2N-NONOates to cobalt(III) centers Angewandte Chemie International Edition 48 2009 8909 8913
78. A.B. Seabra, G.F. de Souza, L.L. da Rocha, M.N. Eberlin, and M.G. de Oliveira S-nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery Nitric Oxide-Biology and Chemistry 11 2004 263 272 (Pubitemid 39573528)
79. S.M. Shishido, A.B. Seabra, W. Loh, and Ganzarolli M. de Oliveira Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release Biomaterials 24 2003 3543 3553 (Pubitemid 36703128)
80. A.B. Seabra, A. Fitzpatrick, J. Paul, M.G. de Oliveira, and R. Weller Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin British Journal of Dermatology 151 2004 977 983 (Pubitemid 39573885)
81. P.G. Wang, M. Xian, X. Tang, X. Wu, Z. Wen, T. Cai, and A.J. Janczuk Nitric oxide donors: chemical activities and biological applications Chemical Reviews 102 2002 1091 1134 (Pubitemid 35377604)
82. 2]Cl Inorganic Chemistry 44 2005 4166 4174 (Pubitemid 40855618)
83. 2+. A nitric oxide precursor Inorganic Chemistry 50 2011 4453 4462
84. N.L. Fry, M.J. Rose, D.L. Rogow, C. Nyitray, M. Kaur, and P.K. Mascharak Ruthenium nitrosyls derived from tetradentate ligands containing carboxamido-N and phenolato-o donors: syntheses, structures, photolability, and time dependent density functional theory studies Inorganic Chemistry 49 2010 1487 1495
85. N.L. Fry, B.J. Heilman, and P.K. Mascharak Dye-tethered ruthenium nitrosyls containing planar dicarboxamide tetradentate N4 ligands: effects of in-plane ligand twist on NO photolability Inorganic Chemistry 50 2011 317 324
86. (n+) complexes: a key role of physiological thiols Journal of Inorganic Biochemistry 105 2011 624 629
87. J. Bordini, D.L. Hughes, J.D. Motta Neto, and C.J. da Cunha Nitric oxide photorelease from ruthenium salen complexes in aqueous and organic solutions Inorganic Chemistry 41 2002 5410 5416
88. K.Q. Ferreira, and E. Tfouni Chemical and photochemical properties of a ruthenium nitrosyl complex with the N-monosubstituted cyclam 1-(3-Propylammonium)-1, 4, 8, 11-tetraazacyclotetradecane Journal of the Brazilian Chemical Society 21 2010 1349 1358
89. 2+ Journal of Inorganic Biochemistry 101 2007 313 320 (Pubitemid 46091803)
90. M.J. Rose, N.L. Fry, R. Marlow, L. Hinck, and P.K. Mascharak Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets Journal of the American Chemical Society 130 2008 8834 8846 (Pubitemid 351962519)
91. III(salen)(Cl) Journal of the American Chemical Society 122 2000 7592 7593 (Pubitemid 30641558)
92. C.F. Works, C.J. Jocher, G.D. Bart, X. Bu, and P.C. Ford Photochemical nitric oxide precursors: synthesis, photochemistry, and ligand substitution kinetics of ruthenium salen nitrosyl and ruthenium salophen nitrosyl complexes Inorganic Chemistry 41 2002 3728 3739
93. F.G. Marcondes, A.A. Ferro, A. Souza-Torsoni, M. Sumitani, M.J. Clarke, D.W. Franco, E. Tfouni, and M.H. Krieger In vivo effects of the controlled NO donor/scavenger ruthenium cyclam complexes on blood pressure Life Sciences 70 2002 2735 2752 (Pubitemid 34312008)
94. S.R. Hutchings, D. Song, S.P. Fricker, and C.C. Pang The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes European Journal of Pharmacology 528 2005 132 136 (Pubitemid 41773663)
95. R. Mosi, B. Seguin, B. Cameron, L. Amankwa, M.C. Darkes, and S.P. Fricker Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger Biochemical Biophysical Research Communications 292 2002 519 529 (Pubitemid 34694294)
96. S.P. Fricker, E. Slade, N.A. Powell, O.J. Vaughan, G.R. Henderson, B.A. Murrer, I.L. Megson, S.K. Bisland, and F.W. Flitney Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases British Journal of Pharmacology 122 1997 1441 1449 (Pubitemid 27503936)
97. S.S. Borges, C.U. Davanzo, E.E. Castellano, Z. Schpector, J.S.C. Silva, and D.W. Franco Ruthenium nitrosyl complexes with N-heterocyclic ligands Inorganic Chemistry 37 1998 2670 2677 (Pubitemid 128477468)
98. M.G. Gomes, C.U. Davanzo, S.C. Silva, L.G.F. Lopes, P.S. Santos, and D.W. Franco Cis- and trans-nitrosyltetraammineruthenium(II). Spectral and electrochemical properties and reactivity Dalton Transactions 1998 601 607 (Pubitemid 128786720)
99. L.G.F. Lopes, M.G. Gomes, S.S.S. Borges, and D.W. Franco Correlation between the lever parameter and electronic properties of nitrosyl ruthenium(II) complexes Australian Journal of Chemistry 51 1998 865 866
100. F. Roncaroli, M.E. Ruggiero, D.W. Franco, G.L. Estiu, and J.A. Olabe Kinetic mechanistic, and DFT study of the electrophilic reactions of nitrosyl complexes with hydroxide Inorganic Chemistry 41 2002 5760 5769
101. J.C. Toledo, H.A.S. Silva, M. Scarpellini, V. Mori, A.J. Camargo, M. Bertotti, and D.W. Franco Ruthenium tetraammines as a model of nitric oxide donor compounds European Journal of Inorganic Chemistry 2004 1879 1885
102. -): modulation of the release of NO by the trans-effect Inorganica Chimica Acta 358 2005 2883 2890 (Pubitemid 40759192)
103. J.H. Enemark, and R.D. Feltham Principles of structure, bonding, and reactivity for metal nitrosyl complexes Coordination Chemistry Reviews 13 1974 339 406
104. P.G. Zanichelli, H.F.G. Estrela, R.C. Spadari-Bratfisch, D.M. Grassi-Kassisse, and D.W. Franco The effects of ruthenium tetraammine compounds on vascular smooth muscle Nitric Oxide-Biology and Chemistry 16 2007 189 196 (Pubitemid 46149390)
105. E.V. Stefaneli, G. Metzker, J.C.M. Pereira, F.C.A. Lima, and D.W. Franco, Selective and controlled HNO and NO formation in the reduction of trans-tetraamminenitrosyltriethylphosphiteruthenium(II) ion. Inorganica Chemica Acta (2011), submitted for publication.
106. P.H. MacArthur, S. Shiva, and M.T. Gladwin Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 851 2007 93 105 (Pubitemid 46720142)
107. +] ion on the surface of functionalized silica gel Langmuir 22 2006 203 208 (Pubitemid 43063539)
108. 2+ Polyhedron 26 2007 4746 4750
109. F.G. Doro, U.P. Rodrigues, and E. Tfouni A regenerable ruthenium tetraammine nitrosyl complex immobilized on a modified silica gel surface. Preparation and studies of nitric oxide release and nitrite-to-NO conversion Journal of Colloid and Interface Science 307 2007 405 417 (Pubitemid 46175831)
110. 6) Journal of the American Chemical Society 126 2004 2546 2555 (Pubitemid 38295736)
111. L.G.F. Lopes, A. Wieraszko, Y. El-Sherif, and M.J. Clarke The trans-labilization of nitric oxide in Ru(II) complexes by C-bound imidazoles Inorganica Chimica Acta 312 2001 15 22 (Pubitemid 32168086)
112. D.R. Lang, J.A. Davis, L.G. Lopes, A.A. Ferro, L.C. Vasconcellos, D.W. Franco, E. Tfouni, A. Wieraszko, and M.J. Clarke A controlled NO-releasing compound: synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of R, R, S, S-trans-[RuCl(NO)(cyclam)]2+ (1, 4, 8, 11-tetraazacyclotetradecane) Inorganic Chemistry 39 2000 2294 2300
113. C.W.B. Bezerra, S.C. da Silva, M.T.P. Gambardella, R.H.A. Santos, L.M.A. Plicas, E. Tfouni, and D.W. Franco Water pi-donation in trans- tetraammineruthenium(II): effect on coordinated-water properties induced by a trans NO ligand Inorganic Chemistry 38 1999 5660 5667
114. J.C. Toledo, L.G.D. Lopes, A.A. Alves, L.P. da Silva, and D.W. Franco Release of NO by a nitrosyl complex upon activation by the mitochondrial reducing power Journal of Inorganic Biochemistry 89 2002 267 271 (Pubitemid 34327268)
115. D.R. Truzzi, A.G. Ferreira, S.C. Silva, E.E. Castellano, F.C.A. Lima, and D.W. Franco Nitrosyl induces phosphorous-acid dissociation in ruthenium(II) Dalton Transactions 40 2011 12917 12925
116. M.G. Sauaia, and R.S. da Silva The reactivity of nitrosyl ruthenium complexes containing polypyridyl ligands Transition Metal Chemistry 28 2003 254 259
117. M.G. Sauaia, F.D. Oliveira, A.C. Tedesco, and R.S. da Silva Control of NO release by light irradiation from nitrosyl-ruthenium complexes containing polypyridyl ligands Inorganica Chimica Acta 355 2003 191 196
118. + complexes European Journal of Inorganic Chemistry 2006 2006 2020 2026
119. Z.N. aa Rocha, R.G. de Lima, F.G. Doro, E. Tfouni, and R.S. da Silva Photochemical production of nitric oxide from a nitrosyl phthalocyanine ruthenium complex by irradiation with light in the phototherapeutic window Inorganic Chemistry Communications 11 2008 737 740
120. A. Wieraszko, M.J. Clarke, D.R. Lang, L.G. Lopes, and D.W. Franco The influence of NO-containing ruthenium complexes on mouse hippocampal evoked potentials in vitro Life Sciences 68 2001 1535 1544 (Pubitemid 32168081)
121. C.R. Pestana, D.P. Phelippin, A.C. Polizello, D.J. Dorta, S.A. Uyemura, A.C. Santos, F.G. Doro, F.P. Rodrigues, E. Tfouni, and C. Curti Effects on mitochondria of mitochondria-induced nitric oxide release from a ruthenium nitrosyl complex Nitric Oxide-Biology and Chemistry 20 2009 24 30
122. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39 (Pubitemid 23020772)
123. A. Artola, and W. Singer Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation Trends in Neurosciences 16 1993 480 487 (Pubitemid 23313527)
124. H.E. Harooni, N. Naghdi, H. Sepehri, and A.H. Rohani The role of hippocampal nitric oxide (NO) on learning and immediate, short- and long-term memory retrieval in inhibitory avoidance task in male adult rats Behavioural Brain Research 201 2009 166 172
125. D.G. Nicholls Bioenergetic: an introduction to the chemiosmotic theory 1982 Academic Press London
126. G. Metzker, D.R. Cardoso, and D.W. Franco, Ruthenium nitrosyls tetraammines as radical scavenger, In: 39 International Conference on Coordination Chemistry, Adelaide - Australia, (2010).
127. B. Halliwell, and J.M. Gutteridge Oxygen toxicity, oxygen radicals, transition metals and disease Biochemical Journal 219 1984 1 14 (Pubitemid 14171443)
128. K.M. Miranda, X. Bu, I. Lorković, and P.C. Ford Synthesis and structural characterization of several ruthenium porphyrin nitrosyl complexes Inorganic Chemistry 36 1997 4838 4848 (Pubitemid 127510440)
129. F. Marquele-Oliveira, D.C.D. Santana, S.F. Taveira, D.M. Vermeulen, A.R.M. de Oliveira, R.S. da Silva, and R.F.V. Lopez Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation Journal of Pharmaceutical and Biomedical Analysis 53 2010 843 851
130. E.B. Caruso, E. Cicciarella, and S. Sortino A multifunctional nanoassembly of mesogen-bearing amphiphiles and porphyrins for the simultaneous photodelivery of nitric oxide and singlet oxygen Chemical Communications 2007 5028 5030 (Pubitemid 350197673)
131. S.A. Cicillini, A.C.L. Prazias, A.C. Tedesco, O.A. Serra, and R.S. da Silva Nitric oxide and singlet oxygen photo-generation by light irradiation in the phototherapeutic window of a nitrosyl ruthenium conjugated with a phthalocyanine rare earth complex Polyhedron 28 2009 2766 2770
132. Z.J. Diwu, and J.W. Lown Phototherapeutic potential of alternative photosensitizers to porphyrins Pharmacology & Therapeutics 63 1994 1 35 (Pubitemid 24250149)
133. A.J. Gomes, L.O. Lunardi, J.M. Marchetti, C.N. Lunardi, and A.C. Tedesco Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment Drug Delivery 12 2005 159 164 (Pubitemid 40604995)
134. B.R. Masters, P.T.C. So, and E. Gratton Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin Biophysical Journal 72 1997 2405 2412 (Pubitemid 27227578)
135. D. Iskander, and R. Weller Nitric oxide suppression of apoptosis in human skin following UV irradiation British Journal of Dermatology 152 2005 847
136. M. Mowbray, S. McLintock, R. Weerakoon, N. Lomatschinsky, S. Jones, A.G. Rossi, and R.B. Weller Enzyme-independent NO stores in human skin: quantification and influence of UV radiation Journal of Investigative Dermatology 129 2009 834 842
137. R. Weller Nitric oxide: a key mediator in cutaneous physiology Clinical and Experimental Dermatology 28 2003 511 514 (Pubitemid 37100555)
138. S.R. Wecksler, A. Mikhailovsky, D. Korystov, and P.C. Ford A two-photon antenna for photochemical delivery of nitric oxide from a water-soluble, dye-derivatized iron nitrosyl complex using NIR light Journal of the American Chemical Society 128 2006 3831 3837
139. 6 compounds: intramolecular redox isomerism of the excited state controlling the photodelivery of NO Inorganic Chemistry 49 2010 6925 6930
140. 6 nitrosyls containing carboxamido-N and carboxylato-O donors: syntheses, structures, and photochemistry Inorganic Chemistry 48 2009 1490 1497
141. M.G. Sauaia, R.G. de Lima, A.C. Tedesco, and R.S. de Silva Photoinduced NO release by visible light irradiation from pyrazi-bridged nitrosyl ruthenium complexes Journal of the American Chemical Society 125 2003 14718 14719 (Pubitemid 37475559)
142. M.G. Sauaia, R.G. de Lima, A.C. Tedesco, and R.S. de Silva Nitric oxide production by visible light irradiation of aqueous solution of nitrosyl ruthenium complexes Inorganic Chemistry 44 2005 9946 9951
143. 2+ Journal of the American Chemical Society 130 2008 168 175
144. 2+ mediated by phosphate ion: visible light generation of nitric oxide for biological targets Journal of Physical Chemistry B 111 2007 6962 6968 (Pubitemid 47152578)
145. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376 (Pubitemid 11169009)
146. C.M. Hu, J.J. Kang, C.C. Lee, C.H. Li, J.W. Liao, and Y.W. Cheng Induction of vasorelaxation through activation of nitric oxide synthase in endothelial cells by brazilin European Journal of Pharmacology 468 2003 37 45 (Pubitemid 36555750)
147. G. Yetik-Anacak, and J.D. Catravas Nitric oxide and the endothelium: history and impact on cardiovascular disease Vascular Pharmacology 45 2006 268 276 (Pubitemid 44765289)
148. D. Bonaventura, F.S. Oliveira, V. Togniolo, A.C. Tedesco, R.S. da Silva, and L.M. Bendhack A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation Nitric Oxide-Biology and Chemistry 10 2004 83 91 (Pubitemid 38591617)
149. A.C. Pereira, P.C. Ford, R.S. da Silva, and L.M. Bendhack Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way Nitric Oxide-Biology and Chemistry 24 2011 192 198
150. 0, 1- system: structure, chemical reactivity and biological assays Journal of Inorganic Biochemistry 98 2004 1921 1932 (Pubitemid 39456428)
151. 2+ induces rat aorta relaxation by ultraviolet light irradiation Nitric Oxide-Biology and Chemistry 13 2005 170 175 (Pubitemid 41443561)
152. 3, a new nitric oxide donor Nitric Oxide-Biology and Chemistry 6 2002 247 254 (Pubitemid 34852368)
153. M.J. Lohse, U. Forstermann, and H.H. Schmidt Pharmacology of NO: cGMP signal transduction Naunyn-Schmiedeberg's Archives of Pharmacology 358 1998 111 112
154. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery British Journal of Pharmacology 124 1998 1131 1140 (Pubitemid 28333935)
155. K.L. Homer, and J.C. Wanstall Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor British Journal of Pharmacology 131 2000 673 682
156. G.B. Wu, E.X. Zhou, and D.X. Qing Tanshinone II(A) elicited vasodilation in rat coronary arteriole: roles of nitric oxide and potassium channels European Journal of Pharmacology 617 2009 102 107
157. A.C. Celotto, C.B. Restini, V.K. Capellini, L.M. Bendhack, and P.R. Evora Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta European Journal of Pharmacology 656 2011 88 93
158. 6) is due to activation of K(Ca) by a cGMP-dependent pathway Vascular Pharmacology 47 2007 139 144 (Pubitemid 47095452)
159. D. Bonaventura, R.G. de Lima, J.A. Vercesi, R.S. da Silva, and L.M. Bendhack Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex Vascular Pharmacology 46 2007 215 222 (Pubitemid 46096814)
160. D. Bonaventura, C.N. Lunardi, G.J. Rodrigues, M.A. Neto, and L.M. Bendhack A novel mechanism of vascular relaxation induced by sodium nitroprusside in the isolated rat aorta Nitric Oxide-Biology and Chemistry 18 2008 287 295
161. L. Li, K. Vaali, I. Paakkari, and H. Vapaatalo Bradykinin, lemakalim and sodium nitroprusside relax the mouse trachea in vitro by different mechanisms Life Sciences 61 1997 PL67 PL73
162. P.R. Shafer, D.E. Wilcox, H. Kruszyna, R. Kruszyna, and R.P. Smith Decomposition and specific exchange of the trans-cyanide ligand on nitroprusside is facilitated by hemoglobin Toxicology and Applied Pharmacology 99 1989 1 10 (Pubitemid 19149138)
163. S. Takabuchi, K. Hirota, K. Nishi, S. Oda, T. Oda, K. Shingu, A. Takabayashi, T. Adachi, G.L. Semenza, and K. Fukuda The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway Biochemical and Biophysical Research Communications 324 2004 417 423 (Pubitemid 39311511)
164. K. Stuart-Smith, D.O. Warner, and K.A. Jones The role of cGMP in the relaxation to nitric oxide donors in airway smooth muscle European Journal of Pharmacology 341 1998 225 233 (Pubitemid 28131119)
165. D. Koesling, E. Bohme, and G. Schultz Guanylyl cyclases, a growing family of signal-transducing enzymes Faseb Journal 5 1991 2785 2791 (Pubitemid 21892849)
166. 2+ signalling mechanisms in vascular myocytes: symposium overview Acta Physiologica Scandinavica 179 2003 339 352 (Pubitemid 38021583)
167. A. Soloviev, V. Lehen'kyi, S. Zelensky, and P. Hellstrand Nitric oxide relaxes rat tail artery smooth muscle by cyclic GMP-independent decrease in calcium sensitivity of myofilaments Cell Calcium 36 2004 165 173 (Pubitemid 38950067)
168. 2+ current in glomus cells of the rabbit carotid body via a cGMP-independent mechanism Journal of Neurophysiology 81 1999 1449 1457 (Pubitemid 29262477)
169. S.L. Archer, J.M.C. Huang, V. Hampl, D.P. Nelson, P.J. Shultz, and E.K. Weir Nitric-oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K-channel by cGMP-dependent protein-kinase Proceedings of the National Academy of Sciences of the United States of America 91 1994 7583 7587 (Pubitemid 24238229)
170. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, and R.A. Cohen Nitric-oxide directly activates calcium-dependent potassium channels in vascular smooth-muscle Nature 368 1994 850 853 (Pubitemid 24137748)
171. D. Bonaventura, F.S. Oliveira, C.N. Lunardi, J.A. Vercesi, R.S. da Silva, and L.M. Bendhack Characterization of the mechanisms of action and nitric oxide species involved in the relaxation induced by the ruthenium complex Nitric Oxide-Biology and Chemistry 15 2006 387 394 (Pubitemid 44647894)
172. C.N. Lunardi, R.S. da Silva, and L.M. Bendhack New nitric oxide donors based on ruthenium complexes Brazilian Journal of Medical and Biological Research 42 2009 87 93
173. G.J. Rodrigues, C.N. Lunardi, R.G. Lima, C.X. Santos, F.R.M. Laurindo, R.S. da Silva, and L.M. Bendhack Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats Nitric Oxide-Biology and Chemistry 18 2008 176 183
174. J.R. Parratt Nitric oxide. A key mediator in sepsis and endotoxaemia? Journal of Physiology and Pharmacology 48 1997 493 506 (Pubitemid 28055582)
175. S. Moncada, and E.A. Higgs The discovery of nitric oxide and its role in vascular biology British Journal of Pharmacology 147 2006 S193 S201
176. E. Karpuzoglu, and S.A. Ahmed Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis Nitric Oxide-Biology and Chemistry 15 2006 177 186 (Pubitemid 44479839)
177. D.R. Cheshire, A. Aberg, G.M. Andersson, G. Andrews, H.G. Beaton, T.N. Birkinshaw, N. Boughton-Smith, S. Connolly, T.R. Cook, A. Cooper, S.L. Cooper, D. Cox, J. Dixon, N. Gensmantel, P.J. Hamley, R. Harrison, P. Hartopp, H. Kack, P.D. Leeson, T. Luker, A. Mete, I. Millichip, D.J. Nicholls, A.D. Pimm, S.A. St-Gallay, and A.V. Wallace The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS) Bioorganic & Medicinal Chemistry Letters 21 2011 2468 2471
178. U. Gradler, T. Fuchss, W.R. Ulrich, R. Boer, A. Strub, C. Hesslinger, C. Anezo, K. Diederichs, and A. Zaliani Novel nanomolar imidazo[4, 5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights Bioorganic & Medicinal Chemistry Letters 21 2011 4228 4232
179. P.G. Wang, T.B. Cai, and N. Taniguchi Nitric oxide donors: for pharmaceutical and biological applications 2005 Wiley-VCH Weinheim
180. N.A. Davies, M.T. Wilson, E. Slade, S.P. Fricker, B.A. Murrer, N.A. Powell, and G.R. Henderson Kinetics of nitric oxide scavenging by ruthenium(III) polyaminocarboxylates: novel therapeutic agents for septic shock Chemical Communications 1997 47 48 (Pubitemid 127496903)
181. K.Q. Ferreira, Síntese, caracterizaão e propriedades químicas e fotoquímicas de nitrosilo complexos de rutênio com ligantes tetraazamacrocíclicos, Departamento de Química - Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto (DQ - FFCLRP), Universidade de São Paulo (USP), Ribeirão Preto (SP) - Brazil, (2004).
182. W. de Souza, Doenas negligenciadas, Academia Brasileira de Ciências, Rio de Janeiro, (2010).
183. Available at < http://www.who.int/topics/tropical-diseases/en/ >, World Health Organization, accessed 1 August 2011.
184. First WHO Report on Neglected Tropical Diseases, available at < http://whqlibdoc.who.int/publications/2010/9789241564090-eng.pdf >, World Health Organization, accessed 1 August 2011.
185. CRS, Neglected Tropical Diseases: Background, Responses, and Issues for Congress, available at: < http://www.fas.org/sgp/crs/misc/R41607.pdf >, accessed August 2011.
186. P. Trouiller, P. Olliaro, E. Torreele, J. Orbinski, R. Laing, and N. Ford Drug development for neglected diseases: a deficient market and a public-health policy failure Lancet 359 2002 2188 2194 (Pubitemid 34694030)
187. Available at < http://www.who.int/neglected-diseases/diseases/chagas/ en > and < http://www.who.int/leishmaniasis/en/ >, World Health Organization, accessed 1 August 2011.
188. Second report of the WHO Expert Committee, available at < http://whqlibdoc.who.int/trs/WHO-TRS-905.pdf >, World Health Organization, accessed 1 August 2011.
189. J.R. Coura, and S.L. Castro A critical review on Chagas disease chemotherapy Memórias do Instituto Oswaldo Cruz 97 2002 3 24 (Pubitemid 135746197)
190. M.C. Chung, E.I. Ferreira, J.L. Santos, J. Giarolla, D.G. Rando, A.E. Almeida, P.L. Bosquesi, R.F. Menegon, and L. Blau Prodrugs for the treatment of neglected diseases Molecules 13 2008 616 677
191. R. Reithinger, J.C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker Cutaneous leishmaniasis Lancet Infectious Diseases 7 2007 581 596 (Pubitemid 47277438)
192. Available at: < http://whqlibdoc.who.int/trs/WHO-TRS-949-eng.pdf >, World Health Organization, accessed 1 August 2011.
193. P. Ascenzi, A. Bocedi, and L. Gradoni The anti-parasitic effects of nitric oxide IUBMB Life 55 2003 573 578 (Pubitemid 38019833)
194. F.R.S. Gutierrez, T.W.P. Mineo, W.R. Pavanelli, P.M.M. Guedes, and J.S. Silva The effects of nitric oxide on the immune system during Trypanosoma cruzi infection Memórias Do Instituto Oswaldo Cruz 104 2009 236 245
195. 2+ as a possible therapeutic approach for Chagas' disease British Journal of Pharmacology 160 2010 270 282
196. J.J. Silva, W.R. Pavanelli, J.C. Pereira, J.S. Silva, and D.W. Franco Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors Antimicrobial Agents and Chemotherapy 53 2009 4414 4421
197. J.J. Silva, P.M. Guedes, A. Zottis, T.L. Balliano, F.O.N. Silva, L.G.F. Lopes, J. Ellena, G. Oliva, A.D. Andricopulo, D.W. Franco, and J.S. Silva Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity British Journal of Pharmacology 160 2010 260 269
198. G.F.P. de Souza, J.K.U. Yokoyama-Yasunaka, A.B. Seabra, D.C. Miguel, M.G. de Oliveira, and S.R.B. Uliana Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis Nitric Oxide-Biology and Chemistry 15 2006 209 216 (Pubitemid 44466428)
199. 50 test Regulatory Toxicology and Pharmacology 42 2005 15 23 (Pubitemid 40724412)
200. N. Paolocci, M.I. Jackson, B.E. Lopez, K. Miranda, C.G. Tocchetti, D.A. Wink, A.J. Hobbs, and J.M. Fukuto The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the janus face of NO Pharmacology & Therapeutics 113 2007 442 458
201. C.H. Switzer, W. Flores-Santana, D. Mancardi, S. Donzelli, D. Basudhar, L.A. Ridnour, K.M. Miranda, J.M. Fukuto, N. Paolocci, and D.A. Wink The emergence of nitroxyl (HNO) as a pharmacological agent Biochimica et Biophysica Acta-Bioenergetics 1787 2009 835 840
202. J.M. Fukuto, K. Chiang, R. Hszieh, P. Wong, and G. Chaudhuri The pharmacological activity of nitroxyl - a potent vasodilator with activity similar to nitric-oxide and or endothelium-derived relaxing factor Journal of Pharmacology and Experimental Therapeutics 263 1992 546 551
203. J.M. Fukuto, C.H. Switzer, K.M. Miranda, and D.A. Wink Nitroxyl (HNO): chemistry, biochemistry, and pharmacology Annual Review of Pharmacology and Toxicology 45 2005 335 355 (Pubitemid 40261809)
204. R.S.F. Silva, E.M. Costa, U.L.T. Trindade, D.V. Teixeira, M.D.F.R. Pinto, G.L. Santos, V.R.S. Malta, C.A. de Simone, A.V. Pinto, and S.L. de Castro Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi European Journal of Medicinal Chemistry 41 2006 526 530
205. N. Hogg Biological chemistry and clinical potential of S-nitrosothiols Free Radical Biology and Medicine 28 2000 1478 1486 (Pubitemid 30604230)
206. A.P. Gobert, S. Semballa, S. Daulouede, S. Lesthelle, M. Taxile, B. Veyret, and P. Vincendeau Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes Infection and Immunity 66 1998 4068 4072 (Pubitemid 28402673)
207. P. Lopez-Jaramillo, C. Ruano, J. Rivera, E. Teran, R. Salazar-Irigoyen, J.V. Esplugues, and S. Moncada Treatment of cutaneous leishmaniasis with nitric-oxide donor Lancet 351 1998 1176 1177 (Pubitemid 28171824)
208. J.A. Coulter, H.O. McCarthy, J. Xiang, W. Roedl, E. Wagner, T. Robson, and D.G. Hirst Nitric oxide - A novel therapeutic for cancer Nitric Oxide-Biology and Chemistry 19 2008 192 198
209. Y. Ling, X.L. Ye, Z.Z. Zhang, Y.H. Zhang, Y.S. Lai, H. Ji, S.X. Peng, and J.D. Tian Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity Journal of Medicinal Chemistry 54 2011 3251 3259
210. L.J. Hofseth, S.P. Hussain, G.N. Wogan, and C.C. Harris Nitric oxide in cancer and chemoprevention Free Radical Biology and Medicine 34 2003 955 968 (Pubitemid 36398556)
211. A. Weyerbrock, B. Baumer, and A. Papazoglou Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro Journal of Neurosurgery 110 2009 128 136
212. C. Chen, Y. Shi, S. Li, Q. Qi, L. Gu, J. Song, and P.G. Wang A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity Archiv der Pharmazie (Weinheim) 339 2006 366 371 (Pubitemid 44213726)
213. 6 complexes Journal of Inorganic Biochemistry 104 2010 489 495
214. B. Serli, E. Zangrando, T. Gianfeffara, L. Yellowlees, and E. Alessio Coordination and release of NO by ruthenium-dimethylsulfoxide complexes - Implications for antimetastases activity Coordination Chemistry Reviews 245 2003 73 83
215. D. Fukumura, S. Kashiwagi, and R.K. Jain The role of nitric oxide in tumour progression Nature Reviews Cancer 6 2006 521 534 (Pubitemid 43980541)
216. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, and J.B. Mitchell The multifaceted roles of nitric oxide in cancer Carcinogenesis 19 1998 711 721 (Pubitemid 28376759)
217. K.D. Kroncke, K. Fehsel, and V. Kolb-Bachofen Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where? Nitric oxide 1 1997 107 120
218. A. Bal-Price, J. Gartlon, and G.C. Brown Nitric oxide stimulates PC12 cell proliferation via cGMP and inhibits at higher concentrations mainly via energy depletion Nitric Oxide-Biology and Chemistry 14 2006 238 246
219. G.C. Brown Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase Biochimica Et Biophysica Acta-Bioenergetics 1504 2001 46 57 (Pubitemid 32179657)
220. B. Brune Nitric oxide: NO apoptosis or turning it ON? Cell Death and Differentiation 10 2003 864 869 (Pubitemid 36939696)
221. D. Hirst, and T. Robson Targeting nitric oxide for cancer therapy Journal of Pharmacy and Pharmacology 59 2007 3 13 (Pubitemid 46133038)
222. L.E. Figueiredo, E.M. Cilli, E.M. Espreafico, and E. Tfouni, Synthesis, characterization, reactivity, and biological activity of ruthenium nitrosyl NO donors with substituted pyridines and a cell penetrating peptide 8th International Congress of Pharmaceutical Sciences - CIFARP, Ribeirão Preto (SP) - Brazil, (2011).
223. 2O encapsulated in microparticles for delivery of nitric oxide toneoplasic cells. 6th International Congress of Pharmaceutical Sciences - CIFARP, Ribeirão Preto (SP) - Brazil, (2007).
224. 2 on B16-F10 tumoral cell, In:XIV Brazilian Meeting on Inorganic Chemistry. I Latin American Meeting on Biological Inorganic Chemistry, Foz do Iguau (PR)- Brazil, (2008).
225. F.W. Flitney, R.J. Pritchard, G.D. Kennovin, S.K. Bisland, D.G. Hirst, and S.P. Fricker Antitumor actions of ruthenium(III)-based nitric oxide scavengers and nitric oxide synthase inhibitors Molecular Cancer Therapeutics 10 2011 1571 1580
226. E. Gianasi, M. Wasil, E.G. Evagorou, A. Keddle, G. Wilson, and R. Duncan HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo European Journal of Cancer 35 1999 994 1002 (Pubitemid 29277137)
227. A.J. Gomes, E.M. Espreafico, and E. Tfouni, Encapsulamento do complexo [Ru(NO)(Hedta)] em micropartículas biodegradáveis e avaliaão sobre células tumorais da linhagem B16-F10, 30 Reunião Anual da Sociedade Brasileira de Química, Águas de Lindóia (MG) - Brazil, (2007).
228. - Inorganica Chimica Acta 343 2003 281 287
229. A.D. Frankel, and C.O. Pabo Cellular uptake of the TAT protein from human immunofeficiency virus Cell 55 1988 1189 1193 (Pubitemid 19020071)
230. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery Journal of Biological Chemistry 276 2001 5836 5840
231. J. Temsamani, and P. Vidal The use of cell-penetrating peptides for drug delivery Drug Discovery Today 9 2004 1012 1019 (Pubitemid 39574557)
232. G. Drin, S. Cottin, E. Blanc, A.R. Rees, and J. Temsamani Studies on the internalization mechanism of cationic cell-penetrating peptides Journal of Biological Chemistry 278 2003 31192 31201 (Pubitemid 36994635)
233. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake Journal of Biological Chemistry 278 2003 585 590 (Pubitemid 36043612)
234. E. Vives, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus Journal of Biological Chemistry 272 1997 16010 16017 (Pubitemid 27265584)
235. E.V. Stevens, A.W. Carpenter, J.H. Shin, J.S. Liu, C.J. Der, and M.H. Schoenfisch Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth Molecular Pharmaceutics 7 2010 775 785
236. G.M. Halpenny, M.M. Olmstead, and P.K. Mascharak Incorporation of a designed ruthenium nitrosyl in PolyHEMA hydrogel and light-activated delivery of NO to myoglobin Inorganic Chemistry 46 2007 6601 6606
237. 3 encapsulated in PLGA nano and microparticles for delivery of nitric oxide to neoplasic cells. Experimental Biology (EB 2008) 2008 San Diego (CA) - USA
238. - Nitric Oxide-Biology and Chemistry 19 2008 245 251
239. A.L. Moura, R.M. Conrado, W.A. Januário, D.W. Franco, E. Tfouni, and R.C. Spadari-Bratfisch, Nitric oxide scavenge property of ruthenium compounds in rat aortic rings. XXVI Reunião da Federaão das Sociedades de Biologia Experimental (FESBE), Rio de Janeiro - Brazil, (2011).
240. Y. Cury, G. Picolo, V.P. Gutierrez, and S.H. Ferreira Pain and analgesia: the dual effect of nitric oxide in the nociceptive system Nitric oxide 25 2011 243 254